• 1
    Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis. Lancet 1956;2:1323 1326.
  • 2
    Cassani F, Bianchi FB, Lenzi M. Immunopathological characterization of anti-nuclear antibodies in chronic liver diseases. J Clin Pathol 1985;38:801 805.
  • 3
    Johnson GD, Holborow EJ, Glynn LF. Antibody to smooth muscle in patients with liver diseases. Lancet 1965;2:878 879.
  • 4
    Walker JG, Doniach D, Roitt IM. Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1965;1:827 831.
  • 5
    Miyachi K, Gupta RC, Dickson ER, Tan EM. Precipitating antibodies to mitochondrial antigens in primary biliary cirrhosis. Clin Exp Immunol 1980;39:599 606.
  • 6
    Berg PA, Binder T, Lindner H, Bannaski H, Maas D, Henning H, Brugel H. Heterogenitat mitochondraler Autoantikorper. Dtsh Med Wschr 1975;100:1123 1129.
  • 7
    Hopf U, Meyer Zum Buschenfelde KH, Arnold W. Detection of a liver membrane autoantibody in HBs Ag negative chronic active hepatitis. N Eng J Med 1976;294:578 582.
  • 8
    McFarlane IG, Wojcicka BM, Zucker GM, Eddleston AL, Williams R. Purification and chracterization of human liver specific membrane lipoprotein (LSP). Clin Exp Immunol 1977;27:381 390.
  • 9
    Rizzetto M, Swana GT, Doniach D. Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol 1973;15: 331 344.
  • 10
    Manns M, Johnson EF, Griffin ICJ, Tan EM, Sullivan KF. The major target of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome p 450 db1. J Clin Invest 1989; 83:1066 1072.
  • 11
    Manns M, Gerken G, Kyriaatsoulis A, Staritz M, Meyer Zum Buschenfelde KH. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987;1:292 294.
  • 12
    Teufel M,niessen KH & Berg PA. Chronic active hepatitis in childhood with detection of liver-pancreas specific autoantibodies. Eur J Pediatr 1983;140:30 33.
  • 13
    Martini E, Abuaf N, Cavalli F, Durand V, Johanet C, Homberg JC. Antibody to liver cytosol (anti-LC 1) in patients with autoimmune chronic active hepatitis type 2. Hepatology 1988;8:1662 1666.
  • 14
    Coppel RL & Gershwin ME. Primary biliary cirrhosis: the molecule and the mimic. Immunol Rev 1995;144:17 49.
  • 15
    Tuaillon N, Andre C, Briand JP, Penner E, Muller S. A lypoyl synthetic octa-decapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis. J Immunology 1992;148:445 450.
  • 16
    McFarlane BM, NcSorley CG, Vergani D, McFarlane IG, Williams R. Serum auto-antibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. Hepatology 1986;3:196 205.
  • 17
    Wacter B, Kyriatosoulis A, Lohse AW, Gerken G, Meyer Zum Buschenfelde KH, Manns M. Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. Hepatology 1990;11: 232 239.
  • 18
    Takano S, Mimori T, Akizuki M, Miyachi K. Serological markers for patients having connective tissue disease associated with autoimmune hepatic diseases. Arthritis Rheum 1992;35(suppl):215.
  • 19
    Schur PH, Moroz LE, Kunkel HG. Precipitating antibodies to ribosomes in the serum patients with systemic lupus erythematosus. Immunochem 1967;4:447 453.
  • 20
    Miyachi K & Tan EM. Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases. Arthritis Rheum 1979;22:87 93.
  • 21
    Homberg JC, Andre C, Abuaf N. A new anti-liver/kidney microsome antibody (anti-LKM 2) in tienillic acid induced hepatitis. Clin Exp Immunol 1984;55:561 570.
  • 22
    Scheuer PJ. Liver Biopsy Interpretation. 4th ed. London:Ballière Tindall, 1988:53 62.
  • 23
    Bianchi L, DeGroote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H et al Acute and chronic hepatitis revisited: review by an international group. Lancet 1977;2:914 919.
  • 24
    Tan EM. Antinuclear antibodies. Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93 151.
  • 25
    Schneider WC & Hogeboom GH. Intracellular distribution of cytochrome C in rat liver homogenates. J Biol Chem 1950;183:123 128.
  • 26
    Miyachi K, Takano S, Matsushima H, Karasawa E, Miki T. A new marker antibody (the MM antibody) for primary biliary cirrhosis–chronic active hepatitis overlap patient. Jpn J Clin Immunol 1988; 11:216 223.
  • 27
    Lowry OH & RosenbroughNh, Farr AI. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265 275.
  • 28
    Lerner MR & Steitz JA. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1979;76:5495 5506.
  • 29
    Francoeur AM & Mathews MB. Interaction between VA RNA and the lupus antigen La. Formation of a ribonucleoprotein particle in vitro. Proc Natl Acad Sci USA 1982;79:6772 6776.
  • 30
    Reimer G, Rose KM, Scheer U. Tan EM. Autoantibody to RNA polymerase 1 in scleroderma sera. J Clin Invest 1987;79:65 72.
  • 31
    Laemmli UK. Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature 1970;227:680 685.
  • 32
    Forman MS, Nakamura MC, Mimori T Gelpi C, Hardin JA. Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled extract. Arthritis Rheum 1985;28:1356 1361.
  • 33
    Klein R & Berg PA. Characterization of a new mitochondrial antigen–antibody (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis. Clin Exp Immunol 1988;74:68 74.
  • 34
    Klein R & Berg PA. Anti-M9 antibodies in sera from patients with primary biliary cirrhosis recognize as epitope of glycogen phosphorylase. Clin Exp Immunol 1990;81:65 71.
  • 35
    Miyakawa H, Kako M, Nagai K, Hino K, Iwabuchi S, Miyachi K, Okamoto H, Mayumi T. HCV-RNA in type 2 autoimmune hepatitis. Amer J Gastroenterology 1991;86:1688 1689.